Botsch's research helps parents and health care providers decide whether or not to continue patching their children who were ...

So the symptoms of retinal vein occlusion can vary. So the first thing is, the patient might tell me that they have a certain hemisphere of their vision that's involved or a small little scotoma ...

If approved, Eylea would be the first treatment for RVO with 8-week dosing. The FDA target action date is Aug. 19, 2025.

Heatwaves can cause a major risk to your eyes - increasing the likelihood of eye strokes due to dehydration and thickened ...

A health condition that requires immediate medical attention to protect eyesight, one has to be particularly careful in ...

Bayer seeks EMA approval for aflibercept 8 mg for treatment of retinal vein occlusion: Berlin Thursday, April 10, 2025, 16:00 Hrs [IST] Bayer has submitted an application to the E ...